These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16212924)

  • 1. Anti-CD137 monoclonal antibody promotes the direct anti-tumor effect mediated by peripheral blood-derived human dendritic cells in vitro.
    Zhang L; Wang Q; Wang X; Ding P; Song J; Ma C; Sun W
    Cell Mol Immunol; 2004 Feb; 1(1):71-6. PubMed ID: 16212924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy with agonistic anti-CD137: two sides of a coin.
    Sun Y; Chen JH; Fu Y
    Cell Mol Immunol; 2004 Feb; 1(1):31-6. PubMed ID: 16212918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-CD137 monoclonal antibody administration augments the antitumor efficacy of dendritic cell-based vaccines.
    Ito F; Li Q; Shreiner AB; Okuyama R; Jure-Kunkel MN; Teitz-Tennenbaum S; Chang AE
    Cancer Res; 2004 Nov; 64(22):8411-9. PubMed ID: 15548712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodies.
    Melero I; Johnston JV; Shufford WW; Mittler RS; Chen L
    Cell Immunol; 1998 Dec; 190(2):167-72. PubMed ID: 9878117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell activation with systemic agonistic antibody versus local 4-1BB ligand gene delivery combined with interleukin-12 eradicate liver metastases of breast cancer.
    Martinet O; Divino CM; Zang Y; Gan Y; Mandeli J; Thung S; Pan PY; Chen SH
    Gene Ther; 2002 Jun; 9(12):786-92. PubMed ID: 12040460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-1BB-mediated immunotherapy of rheumatoid arthritis.
    Seo SK; Choi JH; Kim YH; Kang WJ; Park HY; Suh JH; Choi BK; Vinay DS; Kwon BS
    Nat Med; 2004 Oct; 10(10):1088-94. PubMed ID: 15448685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engagement of the CD137 (4-1BB) costimulatory molecule inhibits and reverses the autoimmune process in collagen-induced arthritis and establishes lasting disease resistance.
    Foell JL; Diez-Mendiondo BI; Diez OH; Holzer U; Ruck P; Bapat AS; Hoffmann MK; Mittler RS; Dannecker GE
    Immunology; 2004 Sep; 113(1):89-98. PubMed ID: 15312139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
    Ahn JS; Krishnadas DK; Agrawal B
    Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The glucocorticoid-induced TNF receptor-related protein (GITR)-GITR ligand pathway acts as a mediator of cutaneous dendritic cell migration and promotes T cell-mediated acquired immunity.
    Kamimura Y; Iwai H; Piao J; Hashiguchi M; Azuma M
    J Immunol; 2009 Mar; 182(5):2708-16. PubMed ID: 19234165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-1BB is expressed on CD45RAhiROhi transitional T cell in humans.
    Garni-Wagner BA; Lee ZH; Kim YJ; Wilde C; Kang CY; Kwon BS
    Cell Immunol; 1996 Apr; 169(1):91-8. PubMed ID: 8612300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humanization of agonistic anti-human 4-1BB monoclonal antibody using a phage-displayed combinatorial library.
    Son JH; Lee UH; Lee JJ; Kwon B; Kwon BS; Park JW
    J Immunol Methods; 2004 Mar; 286(1-2):187-201. PubMed ID: 15087232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of CD137 and CD137 ligand in colorectal cancer patients.
    Dimberg J; Hugander A; Wågsäter D
    Oncol Rep; 2006 May; 15(5):1197-200. PubMed ID: 16596186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired infiltration of tumor-specific cytolytic T cells in the absence of interferon-gamma despite their normal maturation in lymphoid organs during CD137 monoclonal antibody therapy.
    Wilcox RA; Flies DB; Wang H; Tamada K; Johnson AJ; Pease LR; Rodriguez M; Guo Y; Chen L
    Cancer Res; 2002 Aug; 62(15):4413-8. PubMed ID: 12154048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel approach to induce human DCs from monocytes by triggering 4-1BBL reverse signaling.
    Ju S; Ju S; Ge Y; Qiu H; Lu B; Qiu Y; Fu J; Liu G; Wang Q; Hu Y; Shu Y; Zhang X
    Int Immunol; 2009 Oct; 21(10):1135-44. PubMed ID: 19684160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD137 enhances cytotoxicity of CD3(+)CD56(+) cells and their capacities to induce CD4(+) Th1 responses.
    Zhu BQ; Ju SW; Shu YQ
    Biomed Pharmacother; 2009 Aug; 63(7):509-16. PubMed ID: 19019623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
    Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
    Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD137-mediated immunotherapy for allergic asthma.
    Polte T; Foell J; Werner C; Hoymann HG; Braun A; Burdach S; Mittler RS; Hansen G
    J Clin Invest; 2006 Apr; 116(4):1025-36. PubMed ID: 16528411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aging affect the anti-tumor potential of dendritic cell vaccination, but it can be overcome by co-stimulation with anti-OX40 or anti-4-1BB.
    Sharma S; Dominguez AL; Lustgarten J
    Exp Gerontol; 2006 Jan; 41(1):78-84. PubMed ID: 16289924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic vaccination with tumor cells that engage CD137.
    Hellstrom KE; Hellstrom I
    J Mol Med (Berl); 2003 Feb; 81(2):71-86. PubMed ID: 12601523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with dendritic cells pulsed with apoptotic tumors in combination with anti-OX40 and anti-4-1BB monoclonal antibodies induces T cell-mediated protective immunity in Her-2/neu transgenic mice.
    Cuadros C; Dominguez AL; Lollini PL; Croft M; Mittler RS; Borgström P; Lustgarten J
    Int J Cancer; 2005 Oct; 116(6):934-43. PubMed ID: 15856473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.